SCHEMBL17346283

SCHEMBL17346283

CCCCN(CC)CCN(CC)CCSCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 9/20 0.54
OPRM1 P35372 2/20 0.53
DRD3 P35462 2/20 0.53
CHRM2 P08172 1/20 0.53
HTR1A P08908 1/20 0.53
ADRA2A P08913 1/20 0.53
CHRM1 P11229 1/20 0.53
DRD1 P21728 1/20 0.53
SLC6A2 P23975 1/20 0.53
SLC6A4 P31645 1/20 0.53
ADRA1A P35348 1/20 0.53
SLC6A3 Q01959 1/20 0.53
DRD2 P14416 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
CYP2C19 P33261 2/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
BCHE P06276 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24612903 0.89 KCNH2 (0.49) KCNH2OPRM1DRD3CHRM2HTR1A
SCHEMBL21172166 0.87 KCNH2 (0.48) KCNH2OPRM1DRD3CHRM2HTR1A
SCHEMBL17345883 0.84 KCNH2 (0.48) KCNH2OPRM1DRD3CHRM2HTR1A
SCHEMBL17346170 0.84 KCNH2 (0.48) KCNH2OPRM1DRD3CHRM2HTR1A
SCHEMBL24486732 0.83 KCNH2 (0.55) KCNH2OPRM1DRD3CHRM2HTR1A
SCHEMBL1920723 0.81 KCNH2 (0.53) KCNH2OPRM1DRD3CHRM2HTR1A
SCHEMBL17346280 0.81 KCNH2 (0.41) KCNH2OPRM1DRD3CHRM2HTR1A
SCHEMBL17346419 0.79 SIGMAR1 (0.49) KCNH2CYP2C19MAPTCYP1A2CYP3A4
SCHEMBL17346165 0.79 KCNH2 (0.46) KCNH2OPRM1DRD3CHRM2HTR1A
SCHEMBL17346378 0.78 LMNA (0.47) KCNH2OPRM1DRD3DRD2OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN KCNH2 1753/4885OPRM1 274/4885DRD3 455/4885
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN KCNH2 1753/4885OPRM1 274/4885DRD3 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.